Meditation and Substance Use: Alcohol, Cannabis, and Psychedelics in Practice

Most Meditation-Substance Pairings Involve Alcohol and Cannabis, Not Psychedelics

A 2026 cross-sectional study (OpenAlex W7155753175) directly challenges the prevailing narrative that meditation is primarily paired with classic psychedelics. Surveying 1,391 participants, the researchers found that alcohol (29%), cannabis (19%), and nicotine (16%) were far more commonly combined with meditation than classic psychedelics (6%). This finding reframes the discussion around 'psychedelic exceptionalism'—the idea that psychedelics occupy a unique role in contemplative or spiritual practices—and instead situates meditation within broader patterns of polysubstance use.

Notably, the use of classic psychedelics in combination with meditation was not an isolated behavior; it was embedded within a broader context of pronounced polysubstance use. This suggests that individuals who combine meditation with psychedelics are also more likely to use other substances, complicating attempts to draw clear causal links between specific drug-meditation pairings and well-being outcomes.

No Consistent Well-Being Benefit from Combining Psychedelics or Cannabis with Meditation

The study's second phase, focusing on a stratified subsample of 397 classic psychedelic and cannabis users, found no consistent associations between combining these substances with meditation and measures of well-being, peace of mind, psychological flexibility, depression, or anxiety. Regression analyses did not reveal significant positive or negative effects for these combinations, suggesting that the presumed synergy between meditation and psychedelics or cannabis may be overstated in both popular and academic discourse.

However, the researchers uncovered a non-obvious pattern: for other drugs and alcohol, combining use with meditation was associated with better well-being outcomes than using those substances alone. Specifically, individuals who used alcohol or other drugs without meditation reported poorer well-being, while those who combined these substances with meditation did not show the same negative association. Alcohol combined with meditation was even linked to better well-being outcomes compared to alcohol use without meditation. This insight suggests a possible harm reduction mechanism, where meditation may buffer some of the negative effects of certain substances, though causality and mechanisms remain unclear.

Policy and Research Implications: Moving Beyond Psychedelic Exceptionalism

These findings have important implications for both research and clinical practice. First, they urge a shift away from focusing exclusively on psychedelic substances when studying the intersection of contemplative practices and psychoactive use. Researchers and clinicians should instead consider the full spectrum of substances commonly used alongside meditation, including legal and widely available drugs like alcohol and cannabis.

Second, the results highlight the importance of accounting for polysubstance use patterns in both observational and interventional studies. Failing to do so risks conflating the effects of one substance with those of another, or misattributing outcomes to the substance-meditation pairing itself. This is especially relevant for clinical trials and harm reduction programs, which may need to screen for or stratify by concurrent substance use to accurately assess intervention effects.

Finally, the study suggests a potential, if tentative, role for meditation as a harm reduction tool among individuals who use alcohol or other drugs. While the mechanisms remain speculative, this finding could inform the design of integrated behavioral health interventions, especially in settings where abstinence is not the primary goal.

Risks, Unknowns, and Future Directions

The evidence does not support claims that combining psychedelics or cannabis with meditation reliably enhances well-being. The cross-sectional nature of the study precludes causal inference, and self-selection bias may influence results. There is also the risk that individuals with higher baseline well-being are more likely to engage in both meditation and substance use, rather than one causing the other.

Another key unknown is the directionality and mechanism of the apparent harm reduction effect observed with alcohol and other drugs. It is unclear whether meditation actively mitigates substance-related harms, or whether individuals who meditate while using substances differ in unmeasured ways from those who do not. Further, the study does not address acute risks, such as impaired judgment or increased accident risk, that may arise from combining meditation with intoxicants.

For clinicians and harm reduction practitioners, the main takeaway is the need for nuanced, individualized assessment of substance use and contemplative practices. Interventions should be tailored to the specific patterns and motivations of each individual, rather than assuming uniform effects based on substance type.

Looking Ahead: Integrating Polysubstance Use into Psychedelic and Meditation Research

The study's findings point toward a future in which research on meditation and substance use is more ecologically valid, encompassing the full range of substances and behavioral patterns found in real-world settings. For policymakers and funders, this means supporting studies that move beyond psychedelic exceptionalism and address the broader landscape of polysubstance use. For researchers, it calls for more rigorous designs—such as longitudinal or experimental studies—to clarify causality and mechanisms.

Ultimately, the integration of meditation and substance use is a complex, multifaceted phenomenon that defies simple narratives. As the field matures, embracing this complexity will be essential for developing effective interventions and sound policy.

By Dr. Alex Harper, PhD (Neuroscience, University of Cambridge). How we research: This analysis is based on the original study published October 17, 2026, reviewed by Dr. Harper on June 19, 2027. Primary source: OpenAlex W7155753175.